Results 1 to 10 of about 148,335 (302)
The Performance of FDA-Approved PET Imaging Agents in the Detection of Prostate Cancer [PDF]
Biomedicines, 2022 Positron emission tomography (PET) incorporated with X-ray computed tomography (PET/CT) or magnetic resonance imaging (PET/MRI) is increasingly being used as a diagnostic tool for prostate cancer (PCa).
Mei Li, Roman Zelchan, Anna Orlova
doaj +2 more sources
Dendrimer-based contrast agents for PET imaging [PDF]
Drug Delivery, 2017 Positron emission tomography (PET) imaging offers physiological and biological information through the in vivo distribution of PET agents for disease diagnosis, therapy monitoring and prognosis evaluation.
Lingzhou Zhao +2 more
doaj +3 more sources
Progress of PET Imaging Agents for Cardiovascular Diseases
Journal of Isotopes, 2018 Positron emission tomography ( PET) imaging has successfully allowed the noninvasive detection of cardiovascular disease and shows good clinical application prospects. Development and translation application of various imaging agents furtherly enable PET
MA Hui1;LIANG Hong1;XU Wan-bang2;TANG Gang-hua1
doaj +2 more sources
Emerging PET Imaging Agents and Targeted Radioligand Therapy: A Review of Clinical Applications and Trials [PDF]
TomographyTargeted radioligand therapy (RLT) is an emerging field in anticancer therapeutics with great potential across tumor types and stages of disease. While much progress has focused on agents targeting somatostatin receptors and prostate-specific membrane ...
Maierdan Palihati +3 more
doaj +2 more sources
Cyclic Peptides Targeting Granzyme B: Potential Applications as PET Imaging Agents. [PDF]
ACS Med Chem LettThis patent application pertains to macrocyclic peptides and their radiolabeled derivatives, generally represented by Formula I. These compounds exhibit selective binding to Granzyme B (GzmB) and hold the potential for imaging disease or disorders associated with elevated GzmB levels.
Hu QL, Liang SH.
europepmc +3 more sources
Peptide-based PET imaging agent of tumor TIGIT expression
EJNMMI Research, 2023 Abstract Background Accumulating studies have demonstrated that elevated TIGIT expression in tumor microenvironment correlates with better therapeutic response to TIGIT-based immunotherapy in pre-clinical studies. Therefore, a non-invasive method to detect tumor TIGIT expression is crucial to predict the therapeutic ...
Dinghu Weng +5 more
openaire +3 more sources
Translating Molecules into Imaging—The Development of New PET Tracers for Patients with Melanoma
Diagnostics, 2022 Melanoma is a deadly disease that often exhibits relentless progression and can have both early and late metastases. Recent advances in immunotherapy and targeted therapy have dramatically increased patient survival for patients with melanoma.
Laetitia Vercellino +13 more
doaj +1 more source
Approaches to PET Imaging of Glioblastoma
Molecules, 2020 Glioblastoma multiforme (GBM) is the deadliest type of brain tumor, affecting approximately three in 100,000 adults annually. Positron emission tomography (PET) imaging provides an important non-invasive method of measuring biochemically specific targets
Lindsey R. Drake +2 more
doaj +1 more source
[45Ti]Ti-HOPOs: Potential Complexes for the Development of 45Ti PET Imaging Agents [PDF]
ACS OmegaShefali Saini +8 more
doaj +2 more sources
Molecules, 2020 The need for increasingly personalized medicine solutions (precision medicine) and quality medical treatments, has led to a growing demand and research for image-guided therapeutic solutions.
Pedro M. O. Gomes +2 more
doaj +1 more source